X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - WN.COM - Health - 07/Dec 02:38

New GLP-1 Implant May Help Overweight Pets, Study Underway

Key Takeaways ......

Articles similaires

Sorry! Image not available at this time

New GLP-1 Implant May Help Overweight Pets, Study Underway

wn.com - 06/Dec 15:39

Key Takeaways ......

Sorry! Image not available at this time

New GLP-1 Implant May Help Overweight Pets, Study Underway

wn.com - 06/Dec 15:39

Key Takeaways ......

Sorry! Image not available at this time

New GLP-1 Implant May Help Overweight Pets, Study Underway

wn.com - 07/Dec 02:38

Key Takeaways ......

Sorry! Image not available at this time

New GLP-1 Implant May Help Overweight Pets, Study Underway

drugs.com - 06/Dec 11:30

SATURDAY, Dec. 6, 2025 — Weight loss drugs aren’t just for people anymore; They may soon be available for your furry friend.A California company,...

Sorry! Image not available at this time

New GLP-1 Implant May Help Overweight Pets, Study Underway

drugs.com - 06/Dec 11:30

SATURDAY, Dec. 6, 2025 — Weight loss drugs aren’t just for people anymore; They may soon be available for your furry friend.A California company,...

Sorry! Image not available at this time

Shingles Vaccine May Help Slow Dementia, New Study Finds

wn.com - 04/Dec 01:07

Key Takeaways ......

Sorry! Image not available at this time

Shingles Vaccine May Help Slow Dementia, New Study Finds

wn.com - 04/Dec 01:07

Key Takeaways ......

Sorry! Image not available at this time

GLP-1 Medications Show Little Effect on Cancer, Study Shows

wn.com - 10/Dec 20:58

Key Takeaways ......

Sorry! Image not available at this time

GLP-1 Medications Show Little Effect on Cancer, Study Shows

wn.com - 10/Dec 20:58

Key Takeaways ......

Sorry! Image not available at this time

GLP-1 Medications, Such as Ozempic, Zepbound, Show Little Effect on Cancer, Study Shows

drugs.com - 10/Dec 15:12

WEDNESDAY, Dec. 10, 2025 — A new study suggests popular GLP-1 drugs, like Ozempic and Zepbound, may not lower cancer risk as some had...

Les derniers communiqués